Among patients with COPD and type 2 inflammation at an urgent outpatient visit, the ED or hospital, a single dose of add-on rademikibart vs. placebo lowered treatment failure through 4 weeks, ...

A single injection of the next-generation drug rademikibart markedly cut the rate and impact of acute exacerbations among ...

Patients with chronic obstructive pulmonary disease (COPD) and reduced physical activity showed a higher risk of emergency department visits or hospitalizations in a recent study. Patients with ...

Chronic obstructive pulmonary disease (COPD) accounts for approximately 1 million emergency department visits per year. Given the high rates of hospitalization and the cost of caring for patients with ...

The findings, coming from data on more than 900 patients with chronic obstructive pulmonary disease, indicate that as depression severity increased, so did the odds of landing in the hospital.

In Ontario, nearly 900,000 people live with chronic obstructive pulmonary disease (COPD). People with this condition account for 24 per cent of hospitalizations, 24 per cent of emergency department ...

Add Yahoo as a preferred source to see more of our stories on Google. I overheard the EMS radio calling in to the emergency department and could immediately hear the urgency in the voice of the ...

Even relatively small increases in fine-particle air pollution can be followed by more asthma- and chronic obstructive ...

Rademikibart significantly reduced treatment failure and new moderate-to-severe COPD exacerbations in the Seabreeze STAT ...

Connect Biopharma (NASDAQ:CNTB) reported top-line results from its Seabreeze STAT Phase II study of rademikibart in patients ...

Certain neighborhood characteristics, including higher poverty, more uninsured residents, and lower educational attainment, may lead to an increase in COPD-related emergency department visits and ...